| Antiinfectives targeting enzymes and the proton motive force X Feng, W Zhu, LA Schurig-Briccio, S Lindert, C Shoen, R Hitchings, J Li, ... Proceedings of the National Academy of Sciences 112 (51), E7073-E7082, 2015 | 219 | 2015 |
| Predicting and understanding the human microbiome’s impact on pharmacology R Hitchings, L Kelly Trends in pharmacological sciences 40 (7), 495-505, 2019 | 51 | 2019 |
| Mechanism of Fluorinated Anthranilate-Induced Growth Inhibition in Mycobacterium tuberculosis M Nurul Islam, R Hitchings, S Kumar, FL Fontes, JS Lott, NA Kruh-Garcia, ... ACS Infectious Diseases 5 (1), 55-62, 2018 | 23 | 2018 |
| Bacterial hydrogen sulfide drives cryptic redox chemistry in gut microbial communities SJ Wolfson, R Hitchings, K Peregrina, Z Cohen, S Khan, T Yilmaz, ... Nature Metabolism 4 (10), 1260-1270, 2022 | 21 | 2022 |
| Drug metabolism as a community effort R Hitchings, L Kelly Cell metabolism 30 (2), 235-237, 2019 | 7 | 2019 |
| Microbial cysteine degradation drives cryptic sulfide redox chemistry in the gut S Wolfson, R Hitchings, K Peregrina, Z Cohen, S Khan, T Yilmaz, ... | 2 | 2021 |
| Mechanisms of Azoreduction by the Human Gut Microbiome RD Hitchings Albert Einstein College of Medicine, 2021 | 1 | 2021 |
